KELLIE BUNN: Open Payments
NPI 1518248004 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,474 in 75 payments from 13 companies in 2025. Trend: 2023 $1,333 · 2024 $1,929 · 2025 $1,474
Food & beverage: $1,390Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $506 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $203 |
| Madrigal Pharmaceuticals | 5 | $126 |
| Ardelyx, Inc. | 5 | $113 |
| Phathom Pharmaceuticals, Inc. | 8 | $100 |
| Janssen Biotech, Inc. | 2 | $98 |
| QOL Medical, LLC | 4 | $90 |
| Aimmune Therapeutics, Inc. | 4 | $81 |
| PFIZER INC. | 3 | $61 |
| Lilly USA, LLC | 2 | $39 |
Products named: LINZESS, RINVOQ, REZDIFFRA, ENTYVIO, IBSRELA, VOQUEZNA, TREMFYA, Sucraid.
Industry payments across NC — which companies pay providers there.
